US Drug Recall Register
Class III · Low risk Terminated Initiated Sep 28, 2016 (10 years ago)

Clonazepam Tablets

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Impurities/Degradation Specifications: out of specification result for Clonazepam Related Compound (RC) A (a known impurity) at 15 month timepoint.

What was recalled

Clonazepam Tablets, USP, 0.5 mg, packaged in a)100- count unit dose box of 10 x 10 blister cards (NDC 51079-881-20) and b) 300-count unit dose box of 10 x 30 punch cards (NDC 51079-881-56), Rx only, Manufactured by Mylan Pharmaceuticals Inc, Morgantown, WV, 26505

Recalling firm
Mylan Institutional, Inc. (d.b.a. UDL Laboratories)
NDC code
51079-881-20
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0135-2017

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Clonazepam recalls

See all
Class I · High risk Ongoing

Clonazepam Orally Disintegrating Tablets

Reason Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.

Endo USA, Inc. D-0181-2025
Class I · High risk Ongoing

Clonazepam Orally Disintegrating Tablets

Reason Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.

Endo USA, Inc. D-0180-2025
Class I · High risk Ongoing

Clonazepam Orally Disintegrating Tablets

Reason Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.

Endo USA, Inc. D-0179-2025
Class I · High risk Ongoing

Clonazepam Orally Disintegrating Tablet

Reason Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.

Endo USA, Inc. D-0178-2025
Class I · High risk Terminated

Clonazepam Orally Disintegrating Tablets

Reason Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled as 0.125 mg instead of 0.25 mg. The blister strips inside the product carton reflect the correct strength of 0.25 mg.

Endo Pharmaceuticals, Inc. NDC 49884-306-02 D-0622-2024